Acute Respiratory Distress Syndrome immediately following the removal of an aspirated foreign body.
Simpson, R; Myer IV, C; Siracusa, C.
Respiratory Medicine Case Reports.
2020;
29:100978-100978.
Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis with Ivacaftor: Case Series.
Carrion, A; Borowitz, DS; Freedman, SD; Siracusa, CM; Goralski, JL; Hadjiliadis, D; Srinivasan, S; Stokes, DC.
Journal of Pediatric Gastroenterology and Nutrition.
2018;
66:451-454.
CFTR Modulator Therapies in Cystic Fibrosis.
Spielberg, DR; Clancy, JP; Siracusa, C.
TREATMENT OF CYSTIC FIBROSIS AND OTHER RARE LUNG DISEASES.
: Springer Basel;
Springer Basel;
2017.
Non-typeable Haemophilus influenzae purulent pericarditis in a child with cystic fibrosis.
Downes, KJ; Abulebda, K; Siracusa, C; Moore, R; Staat, MA; Poynter, SE.
Pediatrics International.
2016;
58:607-609.
Update in Pediatric Lung Disease 2014.
Siracusa, CM; Brewington, JJ; Brockbank, JC; Guilbert, TW.
American Journal of Respiratory and Critical Care Medicine.
2015;
192:918-923.
Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor.
Siracusa, CM; Ryan, J; Burns, L; Wang, Y; Zhang, N; Clancy, JP; Drotar, D.
Journal of Cystic Fibrosis.
2015;
14:621-626.
Adherence Determinants in Cystic Fibrosis: Cluster Analysis o f Parental Psychosocial, Religious, and/or Spiritual Factors.
Grossoehme, DH; Szczesniak, RD; Britton, LL; Siracusa, CM; Quittner, AL; Chini, BA; Dimitriou, SM; Seid, M.
Annals of the American Thoracic Society.
2015;
12:838-846.